IMATINIB MESYLATE

Formula & Concentration

IMATINIB MESYLATE – imatinib 100 mg tablet

Manufacturer

Aurobindo Pharma*

*Supplied through partnership with Capital Wholesale Co.

Indications

Hypereosinophilic syndrome; unresect or metastatic CD117+ gastrointest stromal tumor; adjuvant therapy of CD117+ gastrointest stromal tumor; myelodysplastic, myeloproliferative diseases with PDGFR; aggressive systemic mastocytosis; accelerated phase Philadelphia chromosome (+) CML; chronic eosinophilic leukemia; Philadelphia chromosome positive ALL; malignancy; lymphoid blast phase Philadelphia chromosome (+) CML; chronic phase Philadelphia chromosome (+) CML; dermatofibrosarcoma protuberans; myeloid blast phase Philadelphia chromosome (+) CML

Product Options

Package Size

NDC #

Presentation

100 mg

59651-0240-90

Tablet

400 mg

59651-0241-30

Tablet

Shelf Life and Storage

Controlled Room Temp (20-25°C)